Vimarsana
Biggest News Aggregation in the World

Page 5 - Mathilde Bohin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mathilde Bohin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mathilde Bohin Today - Breaking & Trending Today

Minutes of Implanet's Annual General Meeting Held on June 9, 2022 - Vimarsana News

Minutes of Implanet's Annual General Meeting Held on June 9, 2022

Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans) (Paris:ALIMP), a medical technology company specializing in vertebral implants, informs

GeNeuro Announces Approval of all Resolutions Proposed at 2022 Annual General Meeting - Vimarsana News

GeNeuro Announces Approval of all Resolutions Proposed at 2022 Annual General Meeting

76.88% of the Company's share capital was represented at the AGM and resolutions were all widely approved Regulatory News: GeNeuro (Euronext Paris: CH0308403085 GNRO), a biopharmaceutical company

Implanet's Annual General Meeting on the Second Call Will Be Held on June 9, 2022 at 2 pm CEST - Vimarsana News

Implanet's Annual General Meeting on the Second Call Will Be Held on June 9, 2022 at 2 pm CEST

Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company specializing in vertebral implants, informs its shareholders

GeNeuro: Availability of Documents and Information for the Annual Shareholders' Meeting of May 31, 2022 - Vimarsana News

GeNeuro: Availability of Documents and Information for the Annual Shareholders' Meeting of May 31, 2022

Regulatory News: GeNeuro (Euronext Paris: CH0308403085 GNRO) (Paris:GNRO), a biopharmaceutical company developing treatments for neurodegenerative and autoimmune diseases, such as multiple sclerosis

IMPLANET Reports Q1 2022 Revenue - Vimarsana News

IMPLANET Reports Q1 2022 Revenue

Q1 2022 revenue doubles to €2.02 million (vs. Q1 2021), driven by the organic growth of its JAZZ activity and the strategic acquisition of OSD Acceleration in activity in France (x2.7) and